TransMedics Group, Inc. Financial Ratios — TMDX Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	-36.24	-51.4	-28.35	-15.4	19.36	54.22
Return on Assets (%)	- -	-112.55	-60.02	-45.5	-22.34	-30.82	-17.59	-5.09	4.7	20.33
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	7.1	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	5.31	- -
Gross Margin (%)	12.34	27.81	44.05	58.73	64.88	69.92	69.84	63.77	59.36	59.92
EBITDA Margin (%)	-363.34	-257.59	-149.56	-120.24	-96.75	-124.28	-29.92	-8.5	12.97	22.42
Operating Margin (%)	-370.2	-265.79	-155.47	-125.42	-102.91	-130.29	-33.64	-11.89	8.49	17.93
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	33.13	43.36
Pretax Margin (%)	-387.58	-270.54	-182.18	-141.95	-112	-145.99	-38.7	-11.04	8.1	17.76
Profit Margin (%)	-387.58	-270.96	-182.5	-142.12	-112.13	-146.11	-38.77	-10.36	8.03	31.43
Net Income to Common Margin (%)	-387.58	-270.96	-182.5	-142.12	-112.13	-146.11	-38.77	-10.36	8.03	31.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.88	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-36.24	-51.4	-28.35	-15.4	19.36	54.22

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	9	34	34	35	44	68	516	518	519
ST Debt	- -	2	- -	- -	- -	- -	1	2	3	13
LT Debt	- -	7	34	34	35	44	66	514	516	506
Total Debt/EBITDA	- -	-0.44	-1.73	-1.2	-1.4	-1.16	-2.42	-25.11	9.05	3.82
Net Debt/EBITDA	- -	0.17	-0.69	-0.5	-0.41	-0.26	5.1	-5.42	3.02	0.18
Total Debt/EBIT	- -	-0.42	-1.66	-1.15	-1.31	-1.11	-2.15	-17.96	13.82	4.78
Net Debt/EBIT	- -	0.16	-0.66	-0.47	-0.38	-0.24	4.53	-3.88	4.6	0.22
EBITDA to Interest Expense	-23.04	-18.47	-7.16	-6.52	-6.23	-9.71	-7.5	-1.9	3.97	9.85
EBITDA-CapEx/Interest Expense	-24.55	-18.71	-7.31	-6.56	-6.34	-10.62	-10.7	-18.5	-5.03	5.55
EBIT to Interest Expense	-23.48	-19.05	-7.44	-6.8	-6.62	-10.18	-8.44	-2.66	2.6	7.88
Interest Expense	1	1	3	4	4	4	4	11	14	14
Common Equity/Total Assets	- -	-843.7	-796.87	51.9	68.4	50.44	67.69	19.46	28.48	44.27
Long-Term Debt/Equity (%)	- -	- -	- -	62.48	33.36	64.55	35.28	374.57	225.53	106.95
Long-Term Debt/Capital (%)	- -	-2.26	-11.14	38.45	25	39.16	25.91	78.66	68.99	50.99
Long-Term Debt/Total Assets (%)	- -	18.5	79.87	32.43	22.8	32.47	23.85	72.79	64.12	47.36
Total Debt/Equity (%)	- -	-5.13	-17.51	62.48	33.36	64.55	36.05	376.05	226.72	109.76
Total Debt/Capital (%)	- -	-2.85	-11.14	38.45	25	39.16	26.48	78.97	69.36	52.33
Total Debt/Total Assets (%)	- -	23.38	79.87	32.43	22.8	32.47	24.38	73.08	64.46	48.6
Net Debt to Equity	- -	1.95	-6.99	25.72	9.7	14.17	-76.04	81.19	75.53	5.08
Net Debt/Capital (%)	- -	1.04	-4.16	20.46	8.83	11.15	-263.99	43.09	42.05	4.77
EBITDA	-23	-20	-19	-28	-25	-38	-28	-21	57	136
EBITDA-CapEx	-24	-20	-20	-29	-25	-41	-40	-200	-72	77
Operating Income (Loss)	-23	-20	-20	-30	-26	-39	-31	-29	37	109

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	2.26	1.61	5.01	10.58	3.98	8.5	7.19	5.62	5.47
Current Ratio	- -	3.12	2.77	6.21	12.36	5.11	10.66	9.3	8.3	7.14
Quick Ratio	- -	2.35	1.89	5.41	11.15	4.23	9.67	8.34	7.25	6.41
CFO/Avg Current Liab	- -	-4.24	-2.22	-2.25	-2.16	-1.64	-1.95	-0.33	0.85	2.58
Common Equity/Total Assets	- -	-843.7	-796.87	51.9	68.4	50.44	67.69	19.46	28.48	44.27
Long-Term Debt/Equity (%)	- -	- -	- -	62.48	33.36	64.55	35.28	374.57	225.53	106.95
Long-Term Debt/Capital (%)	- -	-2.26	-11.14	38.45	25	39.16	25.91	78.66	68.99	50.99
Long-Term Debt/Total Assets (%)	- -	18.5	79.87	32.43	22.8	32.47	23.85	72.79	64.12	47.36
Total Debt/Equity (%)	- -	-5.13	-17.51	62.48	33.36	64.55	36.05	376.05	226.72	109.76
Total Debt/Capital (%)	- -	-2.85	-11.14	38.45	25	39.16	26.48	78.97	69.36	52.33
Total Debt/Total Assets (%)	- -	23.38	79.87	32.43	22.8	32.47	24.38	73.08	64.46	48.6
CFO/Total Liabilities	- -	-11.23	-11.09	-63.74	-62.88	-43.06	-51.04	-2.29	8.48	32.4
CFO/CapEx	-16.31	-87.83	-62.16	-195.67	-66.52	-8.2	-3.85	-0.07	0.38	3.25
Altman's Z-Score	- -	-12.68	-11.8	-1.46	3.12	0.25	10.73	2.69	2.71	5.34

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	16.62	5.97	4.72	3.82	4.73	5.57	5.3	5.47	6.65
Days Sales Outstanding	- -	21.97	61.17	77.29	95.55	77.18	65.5	68.87	66.67	54.86
Inventory Turnover	- -	1.39	0.84	0.95	0.78	0.68	1.59	2.7	3.95	5.09
Days Inventory Outstanding	- -	262.2	432.21	383.94	469.22	537.16	229.62	135.19	92.33	71.77
Accounts Payable Turnover	- -	7.69	2.09	1.95	2.3	3.06	6.79	13.84	15.8	23.74
Accounts Payable Turnover Days	- -	47.45	174.98	186.98	158.68	119.21	53.74	26.36	23.1	15.38
Cash Conversion Cycle	- -	236.72	318.4	274.25	406.09	495.12	241.38	177.7	135.9	111.25
Inventory to Cash Days	- -	-240.24	-371.04	-306.65	-373.68	-459.97	-164.11	-66.32	-25.66	-16.91
Inventories	- -	8	9	11	12	15	21	44	47	49
Raw Materials	- -	3	4	5	7	7	11	26	28	26
Work In Process	- -	1	1	1	1	2	2	4	3	2
Finished Goods	- -	4	5	5	4	6	8	15	15	21
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	270	492	529	1,824	2,567	2,072	4,135
- Cash & Cash Equivalents	- -	12	20	20	25	26	201	395	337	488
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	9	34	34	35	44	68	516	518	519
Enterprise Value	- -	-16	13	223	401	480	1,691	2,688	2,254	4,166
Total Capital	- -	-304	-302	89	139	112	255	653	747	992
Total Debt/Capital (%)	- -	-2.85	-11.14	38.45	25	39.16	26.48	78.97	69.36	52.33
Total Debt / EV	- -	-0.54	2.51	0.15	0.09	0.09	0.04	0.19	0.23	0.12
EV/Sales	- -	- -	1.03	9.47	15.62	15.88	18.09	11.12	5.1	6.88
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	39.36	30.69
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	60.1	38.37
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	35.72	19.18
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	15.26	11.69	15.07
Diluted Market Cap	- -	- -	- -	270	492	529	1,824	2,567	2,196	4,932
Diluted Enterprise Value	- -	-3	13	284	502	547	1,691	2,688	2,377	4,963
EV per Share	- -	- -	0.7	15.73	16.22	17.4	57.2	82.66	67.82	122.56
TTM Sales	6	8	13	24	26	30	93	242	442	605
TTM EBITDA	-23	-20	-19	-28	-25	-38	-28	-21	57	136
TTM Operating Income	-23	-20	-20	-30	-26	-39	-31	-29	37	109
TTM Cash Flow to Firm	-23	-22	-23	-28	-26	-25	-42	-3	63	217
TTM Free Cash Flow to Firm	-22	-22	-23	-28	-26	-21	-30	176	193	276

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-8.41	-16.49	-20.88	-53.8	15.46	12.3	19.56
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	60.1	38.37
Enterprise Value	- -	-16	13	223	401	480	1,691	2,688	2,254	4,166
Low Price	- -	- -	- -	15.74	10.1	17.2	10	36.42	58.27	55
EV/Sales	- -	- -	1.03	9.47	15.62	15.88	18.09	11.12	5.1	6.88
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	39.36	30.69
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	58.42	21.73
Price/Earnings Average	- -	- -	- -	-9.59	-13.82	-17.82	-28.91	-90.27	105.61	18.91
Price/Earnings High	- -	- -	- -	-13.35	-18.04	-30.92	-52.5	-129.44	166.2	27.87
Price/Earnings Low	- -	- -	- -	-6.67	-8.68	-10.74	-8.16	-47.32	54.6	9.83
Price/Book Value	- -	- -	- -	4.94	4.73	7.78	9.72	18.68	9.05	8.74
Price/Book Value Average	- -	- -	- -	5.89	3.82	11.58	5.58	16.44	16.36	7.61
Price/Book Value High	- -	- -	- -	8.2	4.99	20.09	10.14	23.58	25.74	11.21
Price/Book Value Low	- -	- -	- -	4.09	2.4	6.98	1.58	8.62	8.46	3.95
Price/Tangible Book Value	- -	- -	- -	4.94	4.73	7.8	9.74	20.89	9.64	9
Price/Tangible Book Value Average	- -	- -	- -	5.89	3.82	11.61	5.59	18.39	17.43	7.83
Price/Tangible Book Value High	- -	- -	- -	8.2	4.99	20.15	10.15	26.37	27.43	11.54
Price/Tangible Book Value Low	- -	- -	- -	4.09	2.4	7	1.58	9.64	9.01	4.07
Price/Sales	- -	- -	- -	11.44	19.17	17.49	19.52	10.62	4.69	6.83
Price/Sales Average	- -	- -	- -	13.64	15.49	26.04	11.21	9.35	8.48	5.94
Price/Sales High	- -	- -	- -	18.98	20.22	45.17	20.35	13.41	13.35	8.76
Price/Sales Low	- -	- -	- -	9.48	9.73	15.69	3.16	4.9	4.39	3.09
Price/Cash Flow	- -	- -	- -	-8.36	-16.24	-18.33	-39.82	-197.01	42.45	21.44
Price/Cash Flow Average	- -	- -	- -	-9.97	-13.12	-27.3	-22.86	-173.41	76.75	18.66
Price/Cash Flow High	- -	- -	- -	-13.88	-17.13	-47.36	-41.52	-248.67	120.77	27.5
Price/Cash Flow Low	- -	- -	- -	-6.93	-8.24	-16.45	-6.45	-90.9	39.68	9.7
Price/Free Cash Flow Average	- -	- -	- -	-10.02	-13.32	-31.1	-30.89	13.61	22.23	17.02
Price/Free Cash Flow High	- -	- -	- -	-13.95	-17.39	-53.94	-56.1	19.51	34.98	25.09
Price/Free Cash Flow Low	- -	- -	- -	-6.96	-8.37	-18.74	-8.72	7.13	11.49	8.84
EV/Sales Average	- -	- -	1.03	14.23	15.88	26.64	9.78	9.85	8.89	5.99
EV/Sales High	- -	- -	1.03	19.58	20.62	45.78	18.92	13.91	13.76	8.81
EV/Sales Low	- -	- -	1.03	10.07	10.12	16.29	1.73	5.4	4.8	3.14
EV/EBITDA Average	- -	0.17	-0.69	-11.84	-16.42	-21.44	-32.69	-115.83	68.59	26.73
EV/EBITDA High	- -	0.17	-0.69	-16.28	-21.31	-36.83	-63.26	-163.54	106.12	39.29
EV/EBITDA Low	- -	0.17	-0.69	-8.38	-10.46	-13.11	-5.79	-63.52	36.99	14
EV/EBIT Average	- -	0.16	-0.66	-11.35	-15.44	-20.45	-29.07	-82.86	104.73	33.42
EV/EBIT High	- -	0.16	-0.66	-15.61	-20.03	-35.13	-56.26	-116.99	162.03	49.12
EV/EBIT Low	- -	0.16	-0.66	-8.03	-9.84	-12.51	-5.15	-45.44	56.48	17.5
Last Price	- -	- -	- -	19.01	19.9	19.16	61.72	78.93	62.35	121.65
High Price	- -	- -	- -	31.54	20.99	49.5	64.36	99.63	177.37	156
Enterprise Value Average	- -	-3	13	336	407	806	914	2,380	3,927	3,628
Enterprise Value High	- -	-3	13	462	529	1,385	1,769	3,361	6,076	5,334
Enterprise Value Low	- -	-3	13	238	260	493	162	1,305	2,118	1,901

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	19	19	21	27	28	32	33	34	34
Diluted Weighted Avg Shares	14	14	19	14	25	28	30	33	35	41
Basic Weighted Avg Shares	14	14	19	14	25	28	30	33	33	34
Revenue per Share	0.43	0.53	0.68	1.66	1.04	1.1	3.16	7.43	13.29	17.81
EBITDA per Share	-1.56	-1.37	-1.01	-2	-1	-1.36	-0.95	-0.63	1.72	3.99
Operating Income per Share	-1.59	-1.41	-1.05	-2.08	-1.07	-1.43	-1.06	-0.88	1.13	3.19
Basic EPS, GAAP	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.07	5.6
Basic EPS from Cont Ops	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.07	5.6
Diluted EPS, GAAP	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.01	4.69
Diluted EPS from Cont Ops	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.01	4.69
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.67	-1.6	-1.35	-2.27	-1.23	-1.05	-1.55	-0.4	1.47	5.67
Free Cash Flow per Basic Share	-1.77	-1.61	-1.37	-2.28	-1.24	-1.17	-1.95	-5.91	-2.44	3.93
Cash & Equivalents per Share	- -	1.7	1.05	5.68	5.09	3.35	6.81	12.14	10.13	14.37
Book Value per Share	- -	-21.56	-17.45	3.85	4.21	2.46	6.35	4.23	6.89	13.91
Tangible Book Value per Share	- -	-11.65	-9.99	3.85	4.21	2.46	6.34	3.78	6.47	13.52

TransMedics Group, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)